SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: seminole who wrote (892)4/2/1998 10:53:00 PM
From: adam hefian  Read Replies (3) of 1826
 
Looking at the chart 4 years ago MOGN went from $3 to $25 just because the FDA approved Salagen Tablets.What we have now i think is more important stuff,i.e. moving to Phase2 on MGI 114 and a Euro-Partner.That should get us to at least $20 if not more.Hopefully we should hear positive news in the next 30 days.Lets hope that MOGN posts a +ve March qtr.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News